The Effect of Social Support on Treatment Adherence in Hypertension in China

References

• Perumareddi P. Prevention of hypertension related to cardiovascular disease. Prim Care. 2019;46(1):27–39. doi:10.1016/j.pop.2018.10.005
   PubMed Web of Science ®Google Scholar
• Cipolla MJ, Liebeskind DS, Chan SL. The importance of comorbidities in ischemic stroke: impact of hypertension on the cerebral circulation. J Cereb Blood Flow Metab. 2018;38(12):2129–2149. doi:10.1177/0271678X18800589
   PubMed Web of Science ®Google Scholar
• Anupama YJ, Hegde SN, Uma G, Patil M. Hypertension is an important risk determinant for chronic kidney disease: results from a cross-sectional, observational study from a rural population in South India. J Hum Hypertens. 2017;31(5):327–332. doi:10.1038/jhh.2016.81
   PubMed Web of Science ®Google Scholar
• Murray CJ, Aravkin AY, Zheng P, et al. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1223–1249.
   PubMed Web of Science ®Google Scholar
• Oliveros E, Patel H, Kyung S, et al. Hypertension in older adults: assessment, management, and challenges. Clin Cardiol. 2020;43(2):99–107. doi:10.1002/clc.23303
   PubMed Web of Science ®Google Scholar
• Bao M, Wang L. The longitudinal trend of hypertension prevalence in Chinese adults from 1959 to 2018: a systematic review and meta-analysis. Ann Palliat Med. 2020;9(5):2485–2497. doi:10.21037/apm-19-377
   Web of Science ®Google Scholar
• Wang Z, Chen Z, Zhang L, et al. Status of hypertension in china: results from the china hypertension survey, 2012–2015. Circulation. 2018;137(22):2344–2356. doi:10.1161/CIRCULATIONAHA.117.032380
   PubMed Web of Science ®Google Scholar
• Gavrilova A, Bandere D, Rutkovska I, et al. Knowledge about disease, medication therapy, and related medication adherence levels among patients with hypertension. Medicina (Kaunas). 2019;55(11):715.
   Web of Science ®Google Scholar
• Burkhart PV, Sabaté E. Adherence to long-term therapies: evidence for action. J Nurs Scholarsh. 2003;35(3):207. doi:10.1111/j.1547-5069.2003.tb00001.x
   PubMed Web of Science ®Google Scholar
• Animut Y, Assefa AT, Lemma DG. Blood pressure control status and associated factors among adult hypertensive patients on outpatient follow-up at University of Gondar Referral Hospital, northwest Ethiopia: a Retrospective Follow-Up Study. Integr Blood Press Control. 2018;11:37–46. doi:10.2147/IBPC.S150628
   Web of Science ®Google Scholar
• Burnier M. Drug adherence in hypertension. Pharmacol Res. 2017;125(PtB):142–149. doi:10.1016/j.phrs.2017.08.015
   Web of Science ®Google Scholar
• van der Laan DM, Elders PJM, Boons C, Beckeringh JJ, Nijpels G, Hugtenburg JG. Factors associated with antihypertensive medication non-adherence: a systematic review. J Hum Hypertens. 2017;31(11):687–694. doi:10.1038/jhh.2017.48
   PubMed Web of Science ®Google Scholar
• Pan J, Lei T, Hu B, Li Q. Post-discharge evaluation of medication adherence and knowledge of hypertension among hypertensive stroke patients in northwestern China. Patient Prefer Adherence. 2017;11:1915–1922. doi:10.2147/PPA.S147605
   PubMed Web of Science ®Google Scholar
• Osamor PE. Social support and management of hypertension in South-West Nigeria. Cardiovasc J Afr. 2015;26(1):29–33. doi:10.5830/CVJA-2014-066
   PubMed Web of Science ®Google Scholar
• Tan ST, Quek RYC, Haldane V, et al. The social determinants of chronic disease management: perspectives of elderly patients with hypertension from low socio-economic background in Singapore. Int J Equity Health. 2019;18(1):1. doi:10.1186/s12939-018-0897-7
   Web of Science ®Google Scholar
• Ojo OS, Malomo SO, Sogunle PT. Blood pressure (BP) control and perceived family support in patients with essential hypertension seen at a primary care clinic in Western Nigeria. J Family Med Prim Care. 2016;5(3):569–575. doi:10.4103/2249-4863.197284
   PubMedGoogle Scholar
• Nyaaba GN, Stronks K, Meeks K, et al. Is social support associated with hypertension control among Ghanaian migrants in Europe and non-migrants in Ghana? The RODAM Study. Intern Emerg Med. 2019;14(6):957–966. doi:10.1007/s11739-019-02075-7
   PubMed Web of Science ®Google Scholar
• Asgari MR, Bouraghi H, Mohammadpour A, Haghighat M, Ghadiri R. The role of psychosocial determinants in predicting adherence to treatment in patient with hypertension. Interv Med Appl Sci. 2019;11(1):8–16.
   Google Scholar
• Ding W, Li T, Su Q, Yuan M, Lin A. Integrating factors associated with hypertensive patients’ self-management using structural equation modeling: a cross-sectional study in Guangdong, China. Patient Prefer Adherence. 2018;12:2169–2178. doi:10.2147/PPA.S180314
   PubMed Web of Science ®Google Scholar
• Gu L, Wu S, Zhao S, et al. Association of social support and medication adherence in Chinese patients with type 2 diabetes mellitus. Int J Environ Res Public Health. 2017;14(12):1522. doi:10.3390/ijerph14121522
   PubMed Web of Science ®Google Scholar
• Wang J, Zhao X. Family functioning and social support for older patients with depression in an urban area of Shanghai, China. Arch Gerontol Geriatr. 2012;55(3):574–579. doi:10.1016/j.archger.2012.06.011
   PubMed Web of Science ®Google Scholar
• Mao Y, Qiao S, Li X, Zhao Q, Zhou Y, Shen Z. Depression, social support, and adherence to antiretroviral therapy among people living with HIV in Guangxi, China: a Longitudinal Study. AIDS Educ Prev. 2019;31(1):38–50. doi:10.1521/aeap.2019.31.1.38
   PubMed Web of Science ®Google Scholar
• Tao L, Wang M, Zhang X, Du X, Fu L. Exercise adherence in breast cancer patients: a cross-sectional questionnaire survey. Medicine (Baltimore). 2020;99(22):e20427. doi:10.1097/MD.0000000000020427
   Web of Science ®Google Scholar
• Akoko BM, Fon PN, Ngu RC, Ngu KB. Knowledge of hypertension and compliance with therapy among hypertensive patients in the Bamenda health district of Cameroon: a Cross-sectional Study. Cardiol Ther. 2017;6(1):53–67. doi:10.1007/s40119-016-0079-x
   PubMed Web of Science ®Google Scholar
• Xie K, Bao L, Jiang X, et al. The association of metabolic syndrome components and chronic kidney disease in patients with hypertension. Lipids Health Dis. 2019;18(1):229. doi:10.1186/s12944-019-1121-5
   PubMed Web of Science ®Google Scholar
• Kim MT, Hill MN, Bone LR, Levine DM. Development and testing of the Hill-Bone compliance to high blood pressure therapy scale. Prog Cardiovasc Nurs. 2000;15(3):90–96. doi:10.1111/j.1751-7117.2000.tb00211.x
   PubMedGoogle Scholar
• Mutneja E, Yadav R, Dey AB, Gupta P. Frequency and predictors of compliance among patients taking antihypertensive medicines. Indian Heart J. 2020;72(2):136–139. doi:10.1016/j.ihj.2020.03.008
   Google Scholar
• Hashmi SK, Afridi MB, Abbas K, et al. Factors associated with adherence to anti-hypertensive treatment in Pakistan. PLoS One. 2007;2(3):e280. doi:10.1371/journal.pone.0000280
   PubMed Web of Science ®Google Scholar
• Nashilongo MM, Singu B, Kalemeera F, et al. Assessing adherence to antihypertensive therapy in primary health care in Namibia: findings and implications. Cardiovasc Drugs Ther. 2017;31(5–6):565–578. doi:10.1007/s10557-017-6756-8
   PubMed Web of Science ®Google Scholar
• Mweene M, Banda J, Andrews B, Mweene M, Lakhi S. Factors associated with poor medication adherence in hypertensive patients in Lusaka, Zambia. Med J Zambia. 2010;37(3):252–261.
   Google Scholar
• Pan J, Hu B, Wu L, Wang H, Lei T, Liu Z. The translation, reliability and validity of the Chinese version of the Hill-Bone compliance to high blood pressure therapy scale in adults with hypertension. Patient Prefer Adherence. 2020;14:1853–1860. doi:10.2147/PPA.S268031
   PubMed Web of Science ®Google Scholar
• Li G, Hu H, Dong Z, Arao T. Development of the Chinese family support scale in a sample of Chinese patients with hypertension. PLoS One. 2013;8(12):e85682. doi:10.1371/journal.pone.0085682
   Web of Science ®Google Scholar
• Pan J, Wu L, Wang H, et al. Determinants of hypertension treatment adherence among a Chinese population using the therapeutic adherence scale for hypertensive patients. Medicine (Baltimore). 2019;98(27):e16116. doi:10.1097/MD.0000000000016116
   PubMed Web of Science ®Google Scholar
• Yassine M, Al-Hajje A, Awada S, et al. Evaluation of medication adherence in Lebanese hypertensive patients. J Epidemiol Glob Health. 2016;6(3):157–167. doi:10.1016/j.jegh.2015.07.002
   PubMedGoogle Scholar
• Kim Y, Kong KA. Do hypertensive individuals who are aware of their disease follow lifestyle recommendations better than those who are not aware? PLoS One. 2015;10(8):e0136858. doi:10.1371/journal.pone.0136858
   PubMed Web of Science ®Google Scholar
• Yue Z, Bin W, Weilin Q, Aifang Y. Effect of medication adherence on blood pressure control and risk factors for antihypertensive medication adherence. J Eval Clin Pract. 2015;21(1):166–172. doi:10.1111/jep.12268
   PubMed Web of Science ®Google Scholar
• Wang W, Lau Y, Loo A, Chow A, Thompson DR. Medication adherence and its associated factors among Chinese community-dwelling older adults with hypertension. Heart Lung. 2014;43(4):278–283. doi:10.1016/j.hrtlng.2014.05.001
   PubMed Web of Science ®Google Scholar
• Gupta P, Patel P, Štrauch B, et al. Risk factors for nonadherence to antihypertensive treatment. Hypertension. 2017;69(6):1113–1120. doi:10.1161/HYPERTENSIONAHA.116.08729
   PubMed Web of Science ®Google Scholar
• Turan GB, Aksoy M, Çiftçi B. Effect of social support on the treatment adherence of hypertension patients. J Vasc Nurs. 2019;37(1):46–51. doi:10.1016/j.jvn.2018.10.005
   PubMed Web of Science ®Google Scholar
• Ladin K, Daniels A, Osani M, Bannuru RR. Is social support associated with post-transplant medication adherence and outcomes? A systematic review and meta-analysis. Transplant Rev (Orlando). 2018;32(1):16–28. doi:10.1016/j.trre.2017.04.001
   PubMedGoogle Scholar
• Chandran A, Benning L, Musci RJ, et al. The longitudinal association between social support on HIV medication adherence and healthcare utilization in the women’s interagency HIV Study. AIDS Behav. 2019;23(8):2014–2024. doi:10.1007/s10461-018-2308-x
   Web of Science ®Google Scholar
• Berra E, Azizi M, Capron A, et al. Evaluation of adherence should become an integral part of assessment of patients with apparently treatment-resistant hypertension. Hypertension. 2016;68(2):297–306. doi:10.1161/HYPERTENSIONAHA.116.07464
   PubMed Web of Science ®Google Scholar
• Gupta P, Patel P, Horne R, Buchanan H, Williams B, Tomaszewski M. How to screen for non-adherence to antihypertensive therapy. Curr Hypertens Rep. 2016;18(12):89. doi:10.1007/s11906-016-0697-7
   PubMed Web of Science ®Google Scholar